Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Companies showing net profitability are a good investment. And certainly ELTP which shows three consecutive quarters of profit in a row.
Last thing they reported was net profitability for the third consecutive quarter in a row. I don´t think that is bad, does it?! Next thing they will report is the fourth consecutive quarter in a row of net profitability and at that moment you will hate yourself for not having bought at $.06-$0,10.
This sleeping giant is awakening. Short term target (next quarter) $0,2/share mid term target (1year) $0,5/share
Going to $0,2/soon. Net profitable.
Net profitability for 3 consecutive quarters. All the rest I have read here for today is bull xxit
I agree with you.
Three consecutive quarters of net profitability. Significantly undervalued!
Can you tell me more about it please? I was already very bullish because of three consecutive quarters of net profitability.
Yes,very excited indeed
Three consecutive quarters of net profitability. If I were a CEO I would certainly not do a buy back of shares. What would be the use of that in heavens' sake! I am sure that if the company shows net profitability the next quarter, the share price will be at $0.2/share. As a CEO I would continue accumulating profits. With the continuous money inflow I would update my manufacturing facility and make production contracts with other pharmaceutical companies, and look for takeover/merger possibilities.
In the COVID19 period Elite is one of the few companies showing profitability, they are in a great position. Generics are the future.
Another day of net profitability. $$$
I like the accumulation of cash b|c they are net profitable. And I agree with you Nasdaq.
Absolutely
Company is net profitable for three consecutive quarters. No surprises needed. Share price will go up automatically.
1. Current stock price is irrelevant. Look at Gameshop, Tesla, CVM, NWBO, ...
2. 8 years, most pharma companies are not even net profitable after 10 years!
3. Dropping revenue, EVER heard of COVID19? The fact that they were profitable in the worst period in COVID19 shows their incredible strength and LT potential.
I agree. Going to $0,2/share soon if the next quarterly results show net profitability again.
One more net profitable quarter and SP=$0,2/SHARE
It is great to see net profitability here.
This sleeping giant is waking up.
50,000 shares have been bought. Things are moving up.
Me too. Price target within 5yearq:$5/share at least
The trial didn´t stop because for superior efficacy because of the unexpected high number of patients crossing over from placebo to dcvax-l. And because the primary endpoint was PFS, it was too hard to determine PFS/pseudo PFS. that´s the only reason.
So only the bullish case remains. Do your dd.
Excellent!!!
This retrace is what we needed. If I wouldn´t have been in a meeting, I probably would have sold to be honest.
Price might retrace a little to $1,36. Rsi in overbought zone now. I am pretty sure 1,36 support will hold however.
LP will release TLD intraday after sudden halt. Could be today, next week, who knows...
"In contrast to chemotherapy, the focus is the manufacture of a personalised vaccine from blood/tumour antigens which will strengthen the body’s immune system, helping it to identify and attack the cancer cells. The protocol starts at around £65,000 but with flights, accommodation, maintenance trips etc we are probably looking at at least £100,000 in the first year".
Hope Dcvax-l will save her.
Another patient getting dcvax-l!!
https://www.gofundme.com/f/help-lisa-fight-deadly-brain-cancer
I see the same pattern like in RLFTF: volume kepy increasing when it was gradually (day by day) going from up from $.045 to $0.8/share
After TLD COMES out we´ll going to be near a $21b market cap. Being a 20-bagger like RLFTF.
Buy rating in Germany as well. Volume also increasing. In a couple of days we will see even more substantial rises in volumes of 100,000,000 shares and more.
"Damit kommt unsere Redaktion zu dem Befund, das Unternehmen sei als “Buy” einzustufen. Zusammengefasst ist die Redaktion somit der Auffassung, die Aktie von Northwest Biotherapeutics sei bezogen auf die Anlegerstimmung mit “Buy” angemessen bewertet."
https://www.finanztrends.info/northwest-biotherapeutics-unglaubliche-entwicklung/
The announcement will be intraday after sudden halt is announced. Could be tomorrow, next week, who knows...
In Europe already $1,18/share now https://www.wallstreet-online.de/aktien/northwest-biotherapeutics-aktie
“DEDUCED RECKONING: Northwest Biotherapeutics is finally ready for prime time”
https://eu.heraldtribune.com/story/business/2020/10/14/deduced-reckoning-northwest-biotherapeutics-ready-prime-time/3656047001/
LP will release the P3 results intraday IMHO. After halting the stock. That way the naked and “legal” shorts will be destroyed and the stock can maybe jump to $20 and higher.
Thank you. $20/share is double based on the increase in efficacy of the entire dcvax pipeline when dcvax-l shows positive p3 results
How richly?
It is a plenary session and late breaking!
You don´t do a plenary session with late breaking results when you think you will fail. Use your brains please.
Yes I agree
LindaLiau will discuss the primary endpoint result and safety. Which can be easily done in 15min.
Legal consult?